๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Variability of tumor volumes in T3-staged head and neck tumors

โœ Scribed by Frank A. Pameijer; Alfons J. M. Balm; Frans J. M. Hilgers; Sara H. Muller


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
274 KB
Volume
19
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

โœฆ Synopsis


Background: The Tumor Node Metastasis (TNM) classification system describes head and neck tumors using anatomic or unidimensional criteria and may therefore fail to define the actual three-dimensional tumor bulk. To investigate this we measured variability of tumor volumes (Vvol) in T3-staged head and neck tumors.

Methods: Patient material consisted of pretreatment computerized tomography (CT) scans of 71 patients, seen between 1990 and 1995, with T3 head and neck carcinoma involving different subsites. Computerized tomographic scans of 42 patients displayed distinct tumor boundaries and were free of motion and/or dental artifacts. Using these scans, tumor volumes were measured using the summation-of-areas technique, and Vvol was determined.

Results: Following are the tumor-volume measurements: T3 larynx carcinoma (n = 12) Vvol, 1.7-17.0 mL (median 3.7 mL); T3 oropharynx carcinoma (n = 13) Vvol, 10.0-41.2 mL (median 18.3 mL); T3 hypopharynx carcinoma (n = 10) Vvol, 8.9-67.8 mL (me-dian 17.4 mL); T3 nasopharynx carcinoma (n = 3) Vvol, 3.7-30.1 mL; T3 maxillary sinus carcinoma (n = 4) Vvol, 56.0-103.1 mL.

Conclusions: T3-Staged tumors of the head and neck show considerable variability of tumor volumes. Incorporation of tumor volume data may further refine the TNM staging system.


๐Ÿ“œ SIMILAR VOLUMES


Molecular analysis of the candidate tumo
โœ Montserrat Sanchez-Cespedes; Kenji Okami; Paul Cairns; David Sidransky ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 106 KB ๐Ÿ‘ 1 views

The candidate tumor-suppressor gene ING1 encodes p33 ING1 , a nuclear protein which physically interacts with TP53. It has been shown that p33 ING1 acts in the same biochemical pathway as TP53, leading to cell growth inhibition. Interestingly, a rearrangement of the ING1 gene was found in a neurobla

DNA alterations in tumor scrapes vs. bio
โœ Carol L. Rosenberg; Erin M. Finnemore; Pamela S. Larson; Christine P. Nogueira; ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 113 KB ๐Ÿ‘ 2 views

Genetic abnormalities in SCCHNs are frequent and may be useful for screening, follow-up and prognosis. A biopsy or resection generally is utilized to identify these alterations but analysis of scraped or exfoliated tumor cells has been proposed as simpler and more versatile. It is unknown how well g

Staging of head and neck squamous cell c
โœ Giorgio Cortesina; Tiziana Martone; Emanuela Galeazzi; Martina Olivero; Antonell ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 347 KB ๐Ÿ‘ 2 views

In head and neck squamous cell carcinomas (HNSCC), metastasis to cervical lymph nodes is a major determinant of patient outcome. To detect metastases, we used the MET oncogene as marker, which encodes the receptor for hepatocyte growth factor/scatter factor, mediating epithelial cell motility and in

Histologic tumor regression grades in sq
โœ O. M. Braun; B. Neumeister; W. Popp; R. Scherrer; E. Dobrowsky; W. Dobrowsky; E. ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 435 KB ๐Ÿ‘ 2 views

Forty-one patients with Stage 111 and IV squamous cell carcinomas (SCC) of the head and neck were treated preoperatively with mitomycin C and 5-fluorouracil and concomitant radiotherapy. Operation specimen were examined histologically, the percentage of vital tumor cells and devitalized tumor cells